Imeglimin improves systemic metabolism by targeting brown adipose tissue and gut microbiota in obese model mice
{{output}}
Imeglimin is a recently developed anti-diabetic drug that could concurrently promote insulin secretion and insulin sensitivity, while its mechanisms of action are not fully understood. Here we show that imeglimin administration could protect mice from high fat... ...
